Navigation Links
Amgen's Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
Date:7/26/2012

stim) and NEUPOGEN® (Filgrastim) sales grew 2 percent driven mainly by an increase in the U.S. average net sales price.
  • Combined U.S. Neulasta and NEUPOGEN sales increased 6 percent driven by increases in the average net sales price and unit demand, offset partially by a decrease in wholesaler inventories.
  • Combined Neulasta and NEUPOGEN sales in the rest of the world (ROW) declined 13 percent due to a decrease in NEUPOGEN unit demand from loss of share to biosimilars and a decrease in the average net sales price of Neulasta and NEUPOGEN.
  • Enbrel® (etanercept) sales increased 11 percent driven primarily by an increase in the average net sales price, as well as increases in unit demand and wholesaler inventories.
  • Aranesp®(darbepoetin alfa) sales decreased 8 percent driven primarily by a decline in unit demand. 
  • U.S. sales decreased 11 percent driven primarily by a decline in unit demand, offset partially by a change in accounting estimates and an increase in the average net sales price.
  • ROW sales decreased 7 percent driven primarily by a decrease in the average net sales price.
  • EPOGEN®(epoetin alfa) sales decreased 3 percent driven by a reduction in dose utilization, offset largely by reductions in customer discounts and a change in accounting estimates.
  • On a sequential basis, EPOGEN sales increased 18 percent driven by customer and wholesaler buying patterns.  There was a low single-digit percentage point growth in underlying unit demand.
  • Growth-phase products: Sensipar®/Mimpara® (cinacalcet), Vectibix® (panitumumab), and Nplate® (romiplostim) increased 15 percent driven by higher unit demand.
  • Momentum for both XGEVA® (denosumab) and Prolia® (denosumab) continued in the second quarter with solid sequential
    '/>"/>

    • SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
    2. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    3. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
    4. The Female Health Company Reports Second Quarter Operating Results
    5. Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT
    6. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
    7. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
    8. Elsevier Launches Second Annual Mosbys Superheroes of Nursing Contest During Nurses Week 2012
    9. BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
    10. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine
    11. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/19/2013)... , June 19, 2013  Caradigm ... 4.0, a solution designed to help healthcare ... and data while supporting their compliance with ... Provisioning represents a milestone in the delivery ... analytics capabilities for health systems. ...
    (Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf )      (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...
    (Date:6/19/2013)... DST Health Solutions, LLC (DSTHS), a leading ... integrated delivery systems, and health care providers, has announced ... (MDMS) has jumped significantly. A customizable ... of medical prescription drug claims, MDMS allows ... drug claims processes. As specialty drug demand grows due ...
    Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3
    ... SPRING, Md., Feb. 29, 2012   Sunpeaks Ventures, ... or "Sunpeaks Ventures") is pleased to announce that ... Specialists LLC ("HDS"), a value-added distributor of hard-to-find ... distribution business, HDS also owns and markets Clotamin ...
    ... Accuray Incorporated (Nasdaq: ARAY ), ... received the NorthFace ScoreBoard Award(SM) (NFSB ... recognition of achieving excellence in customer service and support in ... Accuray is the first organization also to qualify for outstanding ...
    Cached Medicine Technology:Sunpeaks Ventures Completes Acquisition of Healthcare Distribution Specialists LLC 2Accuray Recognized for Delivering 'World-Class' Customer Service 2Accuray Recognized for Delivering 'World-Class' Customer Service 3Accuray Recognized for Delivering 'World-Class' Customer Service 4
    (Date:6/19/2013)... June 19, 2013 The benefits, ... the sauna but the overall experience for the majority ... positive health-wise. , Mr Mouw, whose Virgina-based company enjoys ... Society’s statement by saying that the type of sauna ... a number of counterfeit imitations which frankly, can be ...
    (Date:6/19/2013)... Daily Gossip issued a press release informing people that ... published on their website at the end of June. Reporters ... about the information they will find on the website. , ... Gossip, the article is a review of the newly published ... during the vast research he has performed that it is ...
    (Date:6/19/2013)... 2013 Researchers from the Icahn ... new studies at ENDO 2013, The Endocrine Society’s ... in San Francisco.     , Mount Sinai researchers showed new ... of prostastic acid phosphatase (PAP) in Prostate Cancer (PCa) ... thyroid gland; revealed the prevalence of primary aldosteronism (PA) ...
    (Date:6/19/2013)... HASCO Medical, Inc. (OTCBB: HASC), ... purchase privately held Auto Mobility Sales, Inc. of ... vehicle sales, service and rentals in southeastern Florida. ... and expands HASCO's strategy of becoming a leading ... The acquisition is subject to customary closing conditions, ...
    (Date:6/19/2013)... Nashville, TN (PRWEB) June 19, 2013 ... the appointment of Dr. John Baxter to Vice President, ... currently serves as Director, Mental Health Services for CCA. ... "It is an honor and great privilege to lead ... offers the unique opportunity to serve society and our ...
    Breaking Medicine News(10 mins):Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2
    ... Children with eczema, a chronic skin condition that often begins ... food allergies. The number of children with eczema is ... new study soon to be published in The Journal ... eczema. Researchers found that dog ownership among children with ...
    ... breast cancer that also have mutations in the BRCA gene ... those with the same disease without the deleterious genetic mutation, ... Cancer Center. The findings may offer a direction for ... negative breast cancer patients, as well as highlight the unique ...
    ... HealthDay Reporter , WEDNESDAY, Sept. 29 (HealthDay ... effective in relieving knee pain from osteoarthritis, researchers are ... has halted a phase 3 trial of the drug ... replacements. Lead researcher Dr. Nancy E. Lane, director ...
    ... a three-year, $200,000 grant to Claudio Soto, Ph.D., professor ... Center at Houston (UTHealth), to pursue a procedure that ... of this project is to develop an efficient and ... can tell people they are in the process to ...
    ... Melvin and Bren Simon Cancer Center have published the ... brain tissue can occur in breast cancer patients undergoing ... to as "chemobrain," have been known for years. ... brain imaging to study women with breast cancer before ...
    ... September 28, 2010 -- The Accreditation Council for ... approved a set of requirements that are a ... professionalism, transitions in care, and resident well-being. Included ... nation,s 111,000 residents training in ACGME accredited teaching ...
    Cached Medicine News:Health News:Dog ownership is associated with reduced eczema in children with dog allergies 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 2Health News:Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence 3Health News:Novel Drug Eases Osteoarthritis Knee Pain 2Health News:IU researchers: Chemotherapy alters brain tissue in breast cancer patients 2Health News:ACGME board approves final duty hour and supervision standards for resident education 2Health News:ACGME board approves final duty hour and supervision standards for resident education 3
    Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....
    For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
    For the quantitative determination of total glucose in serum....
    Glucose reagent is used for the quantitative determination of glucose in human serum....
    Medicine Products: